ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.130
-0.220 (-5.06%)
At close: Mar 13, 2026, 4:00 PM EDT
4.050
-0.080 (-1.94%)
After-hours: Mar 13, 2026, 7:28 PM EDT
ADC Therapeutics Employees
As of December 31, 2025, ADC Therapeutics had 193 total employees, including 188 full-time and 5 part-time employees. The number of employees decreased by 72 or -27.17% compared to the previous year.
Employees
193
Change (1Y)
-72
Growth (1Y)
-27.17%
Revenue / Employee
$421,539
Profits / Employee
-$738,979
Market Cap
524.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 193 | -72 | -27.17% | 188 | 5 |
| Dec 31, 2024 | 265 | -9 | -3.28% | 263 | 2 |
| Dec 31, 2023 | 274 | -43 | -13.56% | 273 | 1 |
| Dec 31, 2022 | 317 | 5 | 1.60% | 317 | 0 |
| Dec 31, 2021 | 312 | 104 | 50.00% | 312 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Lyell Immunopharma | 300 |
| Rocket Pharmaceuticals | 202 |
| CorMedix | 191 |
| Invivyd | 122 |
| Verastem | 102 |
| Neumora Therapeutics | 95 |
| Prothena Corporation | 67 |
ADCT News
- 3 days ago - ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update - PRNewsWire
- 10 days ago - ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026 - PRNewsWire
- 11 days ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire
- 17 days ago - ADC Therapeutics to Participate in March Investor Conferences - PRNewsWire
- 18 days ago - ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement - PRNewsWire
- 2 months ago - ADC Therapeutics SA (ADCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates - PRNewsWire